Explore evidence

The first COVID-19 case diagnosed in Mali was reported on March 25, 2020.

MaliCOVID-19observed March 25, 2020HAL · Unilimdocument of 67 observations

29 joursYoung et Burgess ont rapporté une période pré-patente de 29 jours pour P. malariae.

MalipaludismeHAL · Unilimdocument of 214 observations

28.7 %Malaria infection prevalence was 28.7% in 2012 among children in the health district of Koutiala, Mali.

Malipaludismeobserved 2012published 2020International journal of environmental research and public healtheurope_pmcdocument of 7 observationsDOI 10.3390/ijerph17186639

58.3 %58.3% of mothers stated they would resort to a medical structure first in the event of discovered sickle cell disease.

Malidrépanocytosepublished 2009Мир науки, культуры, образованияOpenAlexdocument of 12 observations

Au Mali, le paludisme est saisonnier avec un pic d'incidence des cas cliniques et de mortalité entre septembre et novembre.

Malipaludismeobserved septembre-novembreHAL · Unilimdocument of 214 observations

3,699 patientsThe study involved 3699 sickle cell disease patients living in Mali, Senegal, Ivory Coast, Democratic Republic of Congo, Gabon and Cameroon.

Cameroun · Côte d'Ivoire · Gabon · Mali · Sénégaldrépanocytosepublished 2024British journal of haematologyeurope_pmcdocument of 10 observations

1.9 per_1000SMC was associated with a 1.9 ‰ reduction in malaria incidence in the general population of Mali.

MalipaludismeHAL · Unilimdocument of 111 observations

25 %Parmi les patients présentant des symptômes évocateurs de COVID-19 dans l'étude ECoVAM, 25 % ont été testés positifs par test antigénique rapide (Ag-RDT).

MaliCOVID-19HAL · Unilimdocument of 36 observations

86 %PCR testing on 14 biopsies was positive for cutaneous leishmaniasis in 12 patients, representing 86%.

Malicutaneous leishmaniasisobserved 2010published 2012Bulletin de la Societe de pathologie exotique (1990)europe_pmcdocument of 4 observations

28.5 %Parmi 28 échantillons examinés, les schizontes ont été trouvés dans 8 échantillons, soit 28,5 %.

MalipaludismeHAL · Unilimdocument of 214 observations

70 %A pilot study conducted in the central region of Segou found indoor residual spraying (IRS) reduced malaria incidence by 70%.

MalipaludismeHAL · Unilimdocument of 111 observations

66.8 %Hospital admissions for WHO-defined severe malaria were reduced by 66.8% in the combined RTS,S/AS01 E and SMC group compared with the SMC alone group.

Malipaludismepublished 2024The Lancet. Infectious diseaseseurope_pmcdocument of 12 observationsDOI 10.1016/s1473-3099(23)00368-7

360 copies/mLAt day 14, the median viral load of malaria cases treated with artemether-lumefantrine was 360 copies/mL, compared to 720 copies/mL in non-malaria comparisons.

Malicytomegalovirus (CMV)published 2016Journal of clinical virology : the official publication of the Pan American Society for Cleurope_pmcdocument of 6 observations

3 %Le Mali contribue à 3 % des cas et décès mondiaux dus au paludisme.

MalipaludismeHAL · Unilimdocument of 214 observations

0.944 nMP. ovale isolates showed no significant difference in susceptibility to cabamiquine compared to P. falciparum, with a median IC50 of 0.9441 nM.

Malipaludismepublished 2026BMC infectious diseaseseurope_pmcdocument of 4 observations

37,372 parasites/μLLa parasitémie moyenne pour les infections à Plasmodium falciparum chez les individus symptomatiques était de 37 372 parasites/μL.

MalipaludismeHAL · Unilimdocument of 214 observations

28.5 %Among children with sickle cell trait in Mali, the prevalence of severe versus uncomplicated malaria in heterozygous females with the G6PD (A−) polymorphism was 28.5%.

MaliG6PD (A−) polymorphism · paludisme · trait drépanocytairepublished 2011American Journal of HematologyOpenAlexdocument of 9 observationsDOI 10.1002/ajh.22093

18.76 %Une proportion de 18,76 % des personnes infectées par Plasmodium falciparum étaient anémiées (niveau d'hémoglobine < 11 g/dL), avec un intervalle de confiance à 95 % de 14,93 à 22,53 %.

MalianémieHAL · Unilimdocument of 214 observations

77.4 %Cross-reactive antibodies against S were present in 77.4% of BS− samples (42 out of 62).

MalipaludismeHAL · Unilimdocument of 67 observations

760 casesSince the beginning of 2026, a total of 760 cases (232 confirmed; 528 suspected) and two deaths (CFR: 0.26%) of dengue fever have been reported from four AU MS: CAR, Mali, Mauritania, and Senegal.

Mali · Mauritanie · Sénégaldengueobserved 2026Africa CDCdocument of 6 observations

2,951,036 testsOver the 2018–2022 period, 15% (2,951,036) of suspected malaria cases in Mali were tested by thick blood smear microscopy.

Malipaludismeobserved 2018–2022HAL · Unilimdocument of 111 observations

78.2 %In Part B of the trial, Plasmodium falciparum infections were detected on blood-smear examination in 86 participants (78.2%) who received placebo.

Malipaludismepublished 2022The New England journal of medicineeurope_pmcdocument of 5 observations

Artemether-lumefantrine showed comparable therapeutic efficacy in children without severe acute malnutrition and in those with severe acute malnutrition when given in combination with ready-to-use therapeutic food.

Malipaludismepublished 2016BMC medicineeurope_pmcdocument of 5 observations

5.64 %La fréquence de Plasmodium malariae était plus élevée chez les participants asymptomatiques (5,64 %) que chez ceux présentant des symptômes cliniques (2,45 %).

MalipaludismeHAL · Unilimdocument of 214 observations

81.7 %In the COVID-19 sample group (N = 266), the prevalence of antibody responders against S was 81.7% among females.

MaliCOVID-19 · SARS-CoV-2 S proteinHAL · Unilimdocument of 67 observations